Balkrishna Industries

Similar documents
MRF. Result Update. Accumulate

Bharat Petroleum Corporation

MRF. Result Update. Accumulate

Result Update. Sterling Tools. Buy

Skipper. Result Update. Reduce

Result Update. Atul Auto. Accumulate

Maruti Suzuki India. Result Update. Accumulate. Product mix driving margins

Techno Electric & Engineering

Maruti Suzuki India. Result Update. Accumulate. Growth Story Continues. Valuation (x) Estimates (` mn) Q3FY18 Result (` Mn)

Voltas. Result Update. Buy. Q4FY18 Result (` Mn) May 21, 2018

Transport Corporation of India

Berger Paints. Result Update. Downgrade to Reduce (Prev. - Accumulate) Valuation (x) Estimates (` mn) Q2FY18 Result (` Mn) November 06, 2017

Result Update. Sterling Tools. Accumulate

Gujarat State Petronet

Music Broadcast. Result Update. Buy. Valuation (x) Estimates (` Mn) Q1FY18 Result (` Mn)

Result Update. Ahluwalia Contracts. Buy

Larsen & Toubro. Result Update. Accumulate. Valuation (x) Estimates (` Bn) Q1FY18 Result (` Mn) July 26, 2018

INOX Leisure. Result Update. Accumulate. Valuation (x) Estimates (` Mn) Q4FY18 Result (` Mn) May 08, 2018

GSK Pharma. Result Update. Buy

NCC. Result Update. Accumulate

HCC. Result Update. Accumulate. Debt reduction factored in. Valuation (x) Estimates (` mn) Q2FY18 Result (` Mn) November 03, 2017

Simplex Infrastructures

Shemaroo Entertainment

Result Update. Havells. Buy

Skipper. Buy. Result Update. India (Capital Goods) Institutional Research DOLAT CAPITAL

Result Update. Skipper. Sell

Skipper. Accumulate. Result Update. India (Capital Goods) Institutional Research DOLAT CAPITAL

CONCOR. Management Meeting Update. Buy

Result Update. Tech Mahindra. Buy

Transport Corporation of India

Container Corporation of India

Result Update. Khadim India. Buy

Dilip Buildcon. Result Update. Buy. Stellar performance continues

Infosys. Result Update. Buy

Mahanagar Gas. Result Update. Accumulate

Music Broadcast. Annual Report Analysis. Buy. Financials (` mn) August 31, 2018

Page Industries. Annual Report Analysis. Accumulate. FINANCIALS (` Mn) July 14, 2017

Kajaria Ceramics. Result Update. Buy

Result Update. KEI Industries. Buy

Dixon Technologies. Annual Report Analysis. Accumulate. Annual Report The IPO year. FINANCIALS (` Mn)

Particulars Q3FY15 Q3FY14 YoY (%) Q2FY15 QoQ (%) 9MFY15 9MFY14 YoY (%) Net Sales 3,774 3, , ,453 8,

Result Update ITC. Accumulate

ICICI Bank. Result Update. Buy. Mixed bag. Valuation (x) Estimates (` mn) Q3FY18 Result (` Mn)

Kalpataru Power Transmission

Result Update. NIIT Technologies. Buy

Q3FY19 Quarterly Preview IT Services

Result Update. HDFC Bank. Accumulate

Sagar Cement. Result Update. Buy. Valuation (x) Estimates (` mn) Q1FY19 Result (` Mn)

Dilip Buildcon. Visit Note. Buy. FY18E a bumper year! Show continues!

JK Cement. Result Update. Buy. Q3FY18 Result (` Mn)

ICICI Bank. Result Update. Buy

KEC International. Annual Report Analysis. Accumulate

Repco Home Finance REPCO IN

Q3FY13 Q3FY12 YOY(%) Q2FY13

Balkrishna Industries Ltd

Result Update. Yes Bank. Buy

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

Sanofi India. Company Update. Buy

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

BALKRISHNA INDUSTRIES LTD

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Fineotex Chemical Ltd

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Near-term pressure, but long-term outlook positive

Still on track. Exhibit 1: ICT is on track for FY09E

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Ahluwalia Contracts (India)

Bloomberg Code: ATA IN

Visaka Industries Ltd

Cummins India Ltd Bloomberg Code: KKC IN

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

TVS Motors. Source: Company Data; PL Research

Simplex Infrastructures

JK Lakshmi Cement. Source: Company Data; PL Research

South Indian Bank. Result Update. Buy

Bharat Petroleum Corporation

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Maruti Suzuki (RHS) BUY. Operationally In Line; Reiterate Buy. Automobiles October 31, 2014 RESULT REVIEW. Outlook & Valuation.

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

ITC Ltd. RESULT UPDATE 27th October, 2017

Transport Corporation of India Ltd.

Amber Enterprises India Ltd

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research

TTK Prestige Ltd. Result Highlights. Revenue growth of 41% YoY, shows no slowdown yet. OPM at ~15.8%; in line with our estimate

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018

Bayer Cropscience (BYRCS IN)

Transport Corporation of India Ltd.

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

Religare Investment Call

Maruti Suzuki. Source: Company Data; PL Research

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Britannia Industries

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Maruti Suzuki. Source: Company Data; PL Research

Reliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014

Transcription:

Annual Report Analysis Balkrishna Industries Accumulate Distribution expansion is the focus area Balkrishna Industries (BKT) has highlighted the importance of distribution reach and higher number of SKUs to sustain volume growth momentum. Focus will also be on the backward integration through carbon black plant in Bhuj ensuring continuous supply and control on input cost. BKT endeavors to continues its strong growth momentum which will be driven by the expansion in the distribution through entering new geographies and going for deeper penetration in existing areas. Addition in the number of SKUs enables BKT to be a preferred vendor for major OEMs across the globe. With backward integration through carbon black plant in FY19, we feel that gross margins should expand. Distribution headroom and acceptability with more global customers will ensure healthy volume growth of double digit. Volume Growth remains strong Demand for the product profile catered by BKT is mainly driven by the economic development in the developed world. Challenges on growth will remain but BKT strategy to expand its distribution reach and penetrate deeper in its existing areas of presence will enable BKT to grow much ahead of the industry. Global industry is expected to grow in the range of 4% - 5% and we believe that BKT will be able to clock double digit volume growth. Input cost pressure to subside BKT key advantage compared to the competition is to produce equal quality products at a lower cost which is driven by the lower man power cost. However, this has been an accepted strength and BKT has a challenge to handle this cost difference as the input material prices get volatile / show upward trend. Carbon Black is under shortage and has seen a price surge of nearly 2% in the last year. BKT is going to get its carbon black plant up and running in FY19 and thereby negating any supply side issues. At the same time, pricing stability will also come and BKT can expand its margins due to this backward integration from second half of FY219. Raw material supply and currency volatility BKT currency exposure gets a natural hedge continues as 85% of revenues comes from exports. Major chunk of the raw material is imported. BKT also goes for near to medium term contracts for sourcing of key raw material like natural rubber. Policy to buy and stock during a lean period has paid off in the past and BKT will be open to any such opportunities in the future also. With BKT expanding its vendor base for raw material sourcing, risk of timely sourcing and pricing issues gets reduced to a large extent. FINANCIALS (` Mn) Particulars FY16 FY17 FY18 FY19E FY2E Net Sales 32,225 37,279 44,473 51,657 58,934 Growth (%) (14.7) 15.7 19.3 14.2 14.2 EBITDA 8,381 11,32 11,67 14,881 17,98 OPM (%) 26. 3.4 24.9 28.8 3.4 PAT 4,386 7,156 7,393 9,777 11,913 NPM (%) 13.6 19.2 16.6 18.9 2.2 EPS (`) 22.7 37. 38.2 5.6 61.6 Growth (%) (1.3) 63.2 3.3 32.3 21.9 PER (x) 52.1 31.9 3.9 23.4 19.2 ROANW (%) 16.8 2.2 19.3 21.6 21.8 ROACE (%) 15.7 23. 23.2 28.1 3. July 13, 218 CMP ` 1,182 Target / Upside ` 1,356/15% BSE Sensex 36,542 NSE Nifty 11,19 Scrip Details Equity / FV ` 387mn/` 2/- Market Cap ` 229bn USD 3.3bn 52-week High/Low ` 1,352/718 Avg. Volume (no) 484686 NSE Symbol Bloomberg Code BALKRISIND Shareholding Pattern Mar 18 (%) BIL IN Promoters 58.3 MF/Banks/FIs 11. FIIs 18. Public / Others 12.7 17 16 15 14 13 12 11 1 9 BIL Relative to Sensex Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 BIL BSE Sensex Sr. Analyst: Priyank Chandra Tel: +9122 496 9737 E-mail: priyank@dolatcapital.com Analyst: Kushal Shah Tel: +9122 496 9768 E-mail: kushals@dolatcapital.com

Valuation BKT has rapidly progressed as a global player in the OHT segment and with lot of headroom available on distribution front, we expect BKT to grow at more than double the industry growth rate. Margins will further improve due to backward integration and with no major capex in coming 2-3 years, return ratios will expand. Despite the outperformance in the stock price, we believe that BKT is a structural bet and should be accumulated at all dips. Recommend Accumulate with a target price of ` 1,356. KTAs from Directors report and MDA BKT deals with specialized tyre segment and hence due to the nature of the business also deals with higher inventory levels. The developed countries, especially European and USA region, forms major part of the revenue generating economies for such segments. Around 2/3 rd part of the revenue for BKT comes agricultural segment which is characterized as non-cyclical while the rest of the revenue of BKT which majorly comes from industrial, construction and mining segment are cyclical in nature. As major part of BKT s revenue comes from export, the cyclical part of the revenue is dependent on the economic outlook of the world. The OHT segment grew by 4-5% in FY18 and the industry is witnessing good momentum since last 2 years. The industry is facing high shortage of carbon black coupled with increasing raw material prices because of rising crude prices. Despite challenges relating to shortage, BKT faced no production loss in FY18. BKT has planned to overcome the headwind by setting up its own carbon black plant with capacity of 6, MT at the capex of ` 1.5 bn. The plant is expected to commence production by the end of FY19. BKT issued 1:1 bonus shares in the month of December in FY18. BKT operates in the segment which is characterized by high capital requirements as well as being a labor-intensive industry. The segment benefits from stable demand and rarely suffers from any technological disruptions. BKT is also exploring others related segments such as Earthmovers & Mining tyres to push the top line growth further. BKT is also actively looking to capture the market through change in customer preference and hence have forayed into the all-steel OTR radial tyre plant at Bhuj location. BKT also faces challenges from smaller players in the industry, retention of employees and increasing raw material prices. July 13, 218 2

Annual Charts 7, 6, 5, 4, 3, 2, 1, Revenue (` mn) Revenue Growth (%) 58,934 51,657 44,473 37,279 32,225 FY16 FY17 FY18 FY19E FY2E 25 19.3 2 15.7 16.2 14.1 15 1 5 (5) (1) (15) -14.7 FY16 FY17 FY18 FY19E FY2E 21, 18, 15, 12, 9, 6, 3, EBITDA (` mn) EBITDA Margin (%) 32 17,98 31 3.4 3.4 14,881 3 28.8 11,32 11,67 29 8,381 28 27 26. 26 24.9 25 FY16 FY17 FY18 FY19E FY2E 24 FY16 FY17 FY18 FY19E FY2E PAT (` mn) PAT Margin (%) 14, 11,913 12, 9,777 1, 8, 7,156 7,393 6, 4,386 4, 2, FY16 FY17 FY18 FY19E FY2E 21 2.2 2 19.2 18.9 19 18 17 16.6 16 15 14 13.6 13 12 FY16 FY17 FY18 FY19E FY2E July 13, 218 3

ROE (%) ROCE (%) 23 32 3. 21.6 21.8 22 3 28.1 21 28 2.2 19.3 26 2 23. 23.2 24 19 22 18 16.8 2 17 18 15.7 16 16 15 14 FY16 FY17 FY18 FY19E FY2E FY16 FY17 FY18 FY19E FY2E 3, 25, 2, 15, 1, 5, Capacity utilisation Segment sales (%) 1 1 3 3 3 4 4 49 57 66 74 83 FY16 FY17 FY18 FY19E FY2E Achievable Installed Capacity (MTPA) - LHS Sales Volumes (MTPA) - LHS Capcity Utilization (%) - RHS 8 6 4 8 6 4 2 33 33 34 34 34 63 63 63 62 62 FY14 FY15 FY16 FY17 FY18 Agriculture OTR Others 1 8 Sales Channel Profile (%) Geographical Revenue Breakup (%) 4 4 3 3 3 1 9 12 15 16 17 2 22 24 24 26 8 2 15 15 15 15 6 6 19 19 15 15 15 4 77 75 74 74 72 2 FY14 FY15 FY16 FY17 FY18 Replacement OEM Others 4 2 53 54 55 54 54 FY14 FY15 FY16 FY17 FY18 Europe America (North & South) Rest of the World India July 13, 218 4

Income Statement (` Mn) Particulars Mar17 Mar18 Mar19E Mar2E Net Sales 36,616 43,527 5,86 58,4 Other Operating Revenue 663 946 851 894 Total Income 37,279 44,473 51,657 58,934 Total Expenditure 25,959 33,46 36,776 41,27 Cost of Material Consumed 15,731 21,652 24,387 27,279 Purchase of Stock-In-Trade 78 276 Employees Benefit Exp. 2,243 2,488 2,737 3,1 Other Expenses 7,93 9,42 9,653 1,737 EBIDTA (Excl. OI) 11,32 11,67 14,881 17,98 EBIDTA (Incl. OI) 13,816 14,429 18,411 21,614 Other Income 2,496 3,362 3,53 3,77 Interest 214 131 157 125 Depreciation 3,38 3,113 3,44 3,438 PBT & EO Items 1,563 11,185 14,813 18,51 Profit Before Tax 1,563 11,185 14,813 18,51 Tax 3,47 3,792 5,37 6,137 Net Profit 7,156 7,393 9,777 11,913 Balance Sheet (` Mn) Particulars Mar17 Mar18 Mar19E Mar2E Sources of Funds Equity Capital 193 387 387 387 Securities Premium 125 Other Reserves 35,194 4,566 49,212 59,542 Net Worth 35,512 4,952 49,598 59,929 Secured Loans 4,99 2,597 1,298 649 Unsecured Loans 2,915 3,676 1,838 919 Loan Funds 7,824 6,273 3,137 1,568 Deferred Tax Liability 3,528 3,288 3,354 3,421 Total Capital Employed 46,864 5,514 56,89 64,918 Applications of Funds Gross Block 34,38 37,476 4,476 42,976 Less: Accumulated Dep. 5,894 8,987 12,427 15,865 Net Block 28,486 28,49 28,49 27,111 Capital Work in Progress 1,97 1,183 6 375 Investments 13,9 11,113 11,335 11,561 Current Assets, Loans & Advances Inventories 4,597 5,942 6,264 7,156 Sundry Debtors 4,122 5,19 6,264 7,156 Cash and Bank Balance 136 246 9,978 18,754 Loans and Advances 1,89 2,799 2,939 3,86 Other Current Assets 3,49 3,655 3,838 4,3 sub total 14,74 17,661 29,282 4,181 Less : Current Liabilities & Provisions Current Liabilities 1,59 7,728 12,953 14,63 Provisions 182 24 224 247 sub total 1,692 7,932 13,177 14,31 Net Current Assets 3,382 9,729 16,15 25,871 Total Assets 46,864 5,514 56,89 64,918 E Estimates Cash Flow (` Mn) Particulars Mar17 Mar18 Mar19E Mar2E Profit before tax 1,563 11,185 14,813 18,51 Depreciation & w.o. 3,38 3,113 3,44 3,438 Net Interest Exp 72 6 157 125 Direct taxes paid (3,125) (3,858) (5,37) (6,137) Change in Working Capital (1,133) (2,151) 3,356 (99) Other (997) (816) (53) (644) (A) CF from Opt. Activities 8,417 7,533 16,2 13,844 Capex (1,613) (4,19) (2,417) (2,275) Free Cash Flow 6,85 3,424 13,783 11,569 Inc./ (Dec.) in Investments (4,45) 3,49 222 227 Other 321 141 22 256 (B) CF from Invt. Activities (5,337) (919) (1,975) (1,792) Inc./(Dec.) in Debt (5,299) (5,28) (3,137) (1,568) Interest exp net (218) (132) (157) (125) Dividend Paid (Incl. Tax) (644) (1,212) (1,131) (1,583) (C) CF from Financing (6,162) (6,553) (4,424) (3,277) Net Change in Cash (3,81) 61 9,82 8,776 Opening Cash balances 3,196 115 176 9,978 Closing Cash balances 115 176 9,978 18,754 Important Ratios Particulars Mar17 Mar18 Mar19E Mar2E (A) Measures of Performance (%) Gross Margin 57.6 51.7 52.8 53.7 EBIDTA Margin (excl. O.I.) 3.4 24.9 28.8 3.4 Interest / Sales.6.3.3.2 Tax/PBT 32.3 33.9 34. 34. Net Profit Margin 19.2 16.6 18.9 2.2 (B) As Percentage of Net Sales Exc. Duty % of Gross Sales 1.5.4.. Cost of materials consumed 42.4 48.3 47.2 46.3 Employee Benefits Expense 6.1 5.7 5.4 5.2 Other Expenses 21.6 21.6 19. 18.5 (C) Measures of Financial Status Debt / Equity (x).2.2.1. Interest Coverage (x) 64.4 11.5 117.4 172.3 Average Cost of Debt (%) 2.1 1.9 3.3 5.3 Debtors Period (days) 41.1 42.1 45. 45. Closing stock (days) 45.8 49.8 45. 45. Inventory Turnover Ratio (x) 8. 7.3 8.1 8.1 Fixed Assets Turnover (x) 1.1 1.2 1.3 1.4 WC Turnover (x) 1.8 4.5 3.2 2.2 Non-Cash WC (` Mn) 3,246 9,483 6,127 7,117 (D) Measures of Investment EPS (`.) 37. 38.2 5.6 61.6 CEPS (`.) 52.7 54.3 68.4 79.4 DPS (`.) 8. 8. 5. 7. Dividend Payout (%) 21.6 2.9 9.9 11.4 Book Value (`.) 367.4 211.8 256.6 31. RoANW (%) 2.2 19.3 21.6 21.8 RoACE (%) 23. 23.2 28.1 3. RoAIC (%) 24.8 23.3 31.1 39.4 (E) Valuation Ratios CMP (`.) 1,182 1,182 1,182 1,182 P/E (x) 31.9 3.9 23.4 19.2 Market Cap. (`. Mn.) 228,51 228,51 228,51 228,51 MCap/ Sales (x) 6.2 5.2 4.5 3.9 EV (`. Mn.) 236,188 234,528 221,66 211,316 EV/Sales (x) 6.5 5.4 4.4 3.6 EV/EBDITA (x) 2.9 21.2 14.9 11.8 P/BV (x) 3.2 5.6 4.6 3.8 Dividend Yield (%).7.7.4.6 E Estimates July 13, 218 5

DART RATING MATRIX Total Return Expectation (12 Months) Buy > 2% Accumulate 1 to 2% Reduce to 1% Sell < % Rating and Target Price History 14 13 12 Month Rating TP (`) Price (`) * Apr-18 Buy 1,345 1,81 May-18 Buy 1,348 1,118 11 1 9 8 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 BKT Target * As on Recommended Dated DART Team Purvag Shah Managing Director purvag@dolatcapital.com +9122 496 9747 Amit Khurana, CFA Head of Equities amit@dolatcapital.com +9122 496 9745 CONTACT DETAILS Equity Sales Designation E-mail Direct Lines Dinesh Bajaj VP - Equity Sales dineshb@dolatcapital.com +9122 496 979 Kartik Sadagopan VP - Equity Sales kartiks@dolatcapital.com +9122 496 9762 Kapil Yadav VP - Equity Sales kapil@dolatcapital.com +9122 496 9735 Derivatives Strategist Designation E-mail Bhavin Mehta VP - Derivatives Strategist bhavinm@dolatcapital.com +9122 496 975 Equity Trading Designation E-mail P. Sridhar VP and Head of Sales Trading sridhar@dolatcapital.com +9122 496 9728 Chandrakant Ware AVP - Equity Sales Trading chandrakant@dolatcapital.com +9122 496 977 Derivatives Trading Designation E-mail Shirish Thakkar AVP - Derivatives shirisht@dolatcapital.com +9122496 972 Hardik Mehta Sales Trader hardikm@dolatcapital.com +9122496 9748 Dolat Capital Market Private Limited. 2, Rajabahadur Mansion, 1st Floor, Ambalal Doshi Marg, Fort, Mumbai - 4 1

Analyst(s) Certification The research analyst(s), with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in this research report. I. Analyst(s) and Associate (S) holding in the Stock(s): (Nil) II. Disclaimer: This research report has been prepared by Dolat Capital Market Private Limited. to provide information about the company(ies) and sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies) solely for the purpose of information of the select recipient of this report. This report and/or any part thereof, may not be duplicated in any form and/or reproduced or redistributed without the prior written consent of Dolat Capital Market Private Limited. This report has been prepared independent of the companies covered herein. Dolat Capital Market Private Limited. and its affiliated companies are part of a multi-service, integrated investment banking, brokerage and financing group. Dolat Capital Market Private Limited. and/or its affiliated company(ies) might have provided or may provide services in respect of managing offerings of securities, corporate finance, investment banking, mergers & acquisitions, financing or any other advisory services to the company(ies) covered herein. Dolat Capital Market Private Limited. and/or its affiliated company(ies) might have received or may receive compensation from the company(ies) mentioned in this report for rendering any of the above services. Research analysts and sales persons of Dolat Capital Market Private Limited. may provide important inputs to its affiliated company(ies) associated with it. While reasonable care has been taken in the preparation of this report, it does not purport to be a complete description of the securities, markets or developments referred to herein, and Dolat Capital Market Private Limited. does not warrant its accuracy or completeness. Dolat Capital Market Private Limited. may not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. This report is provided for information only and is not an investment advice and must not alone be taken as the basis for an investment decision. The investment discussed or views expressed herein may not be suitable for all investors. The user assumes the entire risk of any use made of this information. The information contained herein may be changed without notice and Dolat Capital Market Private Limited. reserves the right to make modifications and alterations to this statement as they may deem fit from time to time. Dolat Capital Market Private Limited. and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. This report is neither an offer nor solicitation of an offer to buy and/or sell any securities mentioned herein and/or not an official confirmation of any transaction. This report is not directed or intended for distribution to, or use by any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject Dolat Capital Market Private Limited. and/or its affiliated company(ies) to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to a certain category of investors. Persons in whose possession this report may come, are required to inform themselves of and to observe such restrictions. For U.S. Entity/ persons only: This research report is a product of Dolat Capital Market Private Limited., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Dolat Capital Market Private Limited. only to "Major Institutional Investors" as defined by Rule 15a- 6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person or entity. In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Dolat Capital Market Private Limited. has entered into an agreement with a U.S. registered broker-dealer Ltd Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer/entity as informed by Dolat Capital Market Private Limited. from time to time. Dolat Capital Market Private Limited. Corporate Identity Number: U6599DD1993PTC9797 Member: BSE Limited and National Stock Exchange of India Limited. SEBI Registration No: BSE - INB17152 & INF17152, NSE - INB237131& INF237131, Research: INH685 Registered office: Office No. 141, Centre Point, Somnath, Daman 396 21, Daman & Diu Board: +9122 49697 Fax: +9122 22651278 Email: research@dolatcapital.com www.dolatcapital.com Our Research reports are also available on Reuters, Thomson Publishers, DowJones and Bloomberg (DCML <GO>)